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https://doi.org/10.1016/j.celrep.2020.107756SUMMARYImmunodeficiencies are typically caused by loss-of-function mutations in lymphocyte-specific genes. Occa-
sionally, mutations in ubiquitous general-purpose factors, including those affecting essential components of
the DNA polymerase epsilon (POLE) holoenzyme, have cell-type-specific consequences. POLE3, one of the
four components of the POLE holoenzyme, features a histone fold domain and a unique acidic C terminus,
making it a particularly attractive candidate mediating cell type-specific activities of POLE. Mice lacking
Pole3 survive up to late embryonic stages, indicating that this subunit is dispensable for DNA replication.
The phenotypes of viable hypomorphic and neomorphic alleles are surprisingly tissue restricted and reveal
a stage-specific function of the histone fold domain of Pole3 during T and B cell development. Gradual intro-
duction of positively charged residues into the acidic C terminus leads to peripheral lymphopenia of
increasing severity. Our findings serve as a paradigm to understand the molecular basis of cell-type-specific
non-replicative functions of the ubiquitous POLE complex.INTRODUCTION
Cell differentiation in the developing organism is orchestrated by
a complex interplay of extrinsic and cell-intrinsic factors. Lym-
phocytes of the T and B cell lineages fall into a special category,
as they are the only known cell types for which programmedDNA
rearrangements constitute an essential aspect of their matura-
tion process. Therefore, the list of recessive genetic defects
that impair lymphocyte function contains not only genes encod-
ing molecules involved in their communication with the environ-
ment, such as the IL7 receptor (Puel et al., 1998), but also genes
encoding key factors of DNA recombination and repair pro-
cesses, such as the recombination activating genes RAG1 and
RAG2 (Mombaerts et al., 1992; Schwarz et al., 1996), DNA
cross-link repair protein 1c (DCLRE1C; also known as ARTEMIS)
(Moshous et al., 2001), ligase IV (LIG4) (Grawunder et al., 1998;
O’Driscoll et al., 2001), the catalytic subunit of the DNA-depen-
dent kinase (PRKDC) (van der Burg et al., 2009; Woodbine
et al., 2013), and others.
In recent studies, immunodeficiency was found to be associ-
ated with mutations in genes encoding general-purpose factors,
such as those required for DNA replication. For instance, muta-
tions in the gene encoding the catalytic subunit of DNA polymer-
ase epsilon (POLE), POLE1, are associated with multi-organ pa-
thology, including immunodeficiency (FILS syndrome andThis is an open access article under the CC BY-NIMAGe syndrome with variable immunodeficiency) (Logan
et al., 2018; Pachlopnik Schmid et al., 2012). A mutation in the
gene encoding the POLE2 subunit of POLE also causes com-
bined immunodeficiency (Frugoni et al., 2016). These findings
suggest the possibility that specific mutations in other compo-
nents of the POLE holoenzyme complex might also result in
lymphocyte-lineage defects and may even serve as the molecu-
lar link between ubiquitous and cell type-specific functions.
POLE is an evolutionarily conserved, four-component holoen-
zyme that synthesizes the leading strand during DNA replication
(Kunkel and Burgers, 2008). POLE1 is the catalytic subunit of the
holoenzyme, with the POLE2 subunit representing the second
essential component (Araki et al., 1991a; Jaszczur et al., 2008).
The two accessory subunits of the complex, POLE3 and
POLE4, form a heterodimer through their histone fold domains
(Li et al., 2000). They were shown to contribute to the stability
of the POLE holoenzyme, but at least in unicellular organisms,
they are not absolutely essential for growth, as depletion of the
yeast Pole3 and Pole4 homologs does not compromise DNA
replication (Araki et al., 1991b; Ohya et al., 2000). It has been
suggested that POLE3 and POLE4 may serve functions other
than participating in DNA replication; this notion is supported
by the observation that POLE3 (also known as p17) co-purifies
with proteins of the chromatin remodeling complex ACF1-ISWI
(Kukimoto et al., 2004; Poot et al., 2000). The POLE3 subunitCell Reports 31, 107756, June 16, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Late Embryonic Lethality of Pole3 Deficiency
(A) Gross appearance of Pole3+/+ and Pole3/ littermate embryos from two independent experiments at 16.5 days post-coitum (DPC) (top and bottom panels),
illustrating the small size and cranial defects (bottom, indicated by white arrowhead) of Pole3/ embryos.
(B) Alcian blue-alizarin red staining of Pole3+/+ and Pole3/ littermate embryos at 16.5 DPC. Note the incomplete cranial ossifications and shorter rib bones in the
Pole3/ embryo (alizarin red, indicated by black arrowheads); fusion of vertebrae and the shorter tails of the Pole3/ embryo are also evident (Alcian blue,
indicated by red arrowheads).
(C) Flow cytometric profiles of thymocytes of Pole3+/+ and Pole3/ embryos at 16.5 DPC. The distribution of CD8+ SP, CD4+CD8+ (DP), and CD4CD8 (DN)
thymocytes indicates an accumulation of DN and the loss of DP and intermediate SP (ISP) cells in the mutant (upper panels); the distribution of the DN (gdTCR)
thymocyte populations characterized by CD44 and CD25 indicate an accumulation of DN3 cells. The percentages of cells in each gate are indicated.
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OPEN ACCESSdiffers from the POLE4 subunit by the presence of a C-terminal
domain that is enriched for negatively charged amino acids.
This feature can be found in all vertebrate orthologs; however,
its function is unknown. We hypothesized that this protein
domain of POLE3 may link the general replicative functions of
the POLE holoenzyme to cell type-specific activities.
Here, we describe our experiments aimed at elucidating the
enigmatic functions of POLE3. We found that mice homozygous
for a null allele of Pole3 exhibit embryonic lethality only in the last
stages of gestation, clearly demonstrating that this protein is not
essential for cell division; interestingly, this phenotype is reminis-
cent of that of Pole4-deficient mice (Bellelli et al., 2018b). The
phenotypes of an allelic series of Pole3 reported herein demon-
strate that the acidic tail of the POLE3 protein is indeed involved
in mediating cell type-specific functions. Conversion of the
negative charge of the C-terminal domain into a net positive
charge results in a cell-autonomous, stage-specific block of T
and B lymphocyte differentiation in the thymus and bone
marrow, respectively, leading to severe peripheral lymphopenia.
Collectively, our work suggests a possible mechanism through
which the DNA POLE holoenzyme regulates the differentiation
of lymphoid cells.
RESULTS
Late Embryonic Lethality of Pole3 Deficiency
We took a genetic approach to investigate the physiological role
of POLE3 in the mouse. As a first step, we examined the conse-
quences of inactivating the Pole3 gene in the germline of C57BL/
6 mice. Mice homozygous for the Pole3tm1(KOMP)Vlcg null allele
(Figure S1A) died during late stages of embryogenesis around2 Cell Reports 31, 107756, June 16, 2020embryonic day (E) 16.5. Pole3-deficient embryos were smaller
in size than their wild-type littermates and sometimes exhibited
severe cranial defects (Figure 1A). It is possible that the late em-
bryonic lethality in mice with Pole3 and Pole4 (Bellelli et al.,
2018b) deficiencies is the result of partial functional redun-
dancies between these two accessory subunits of the POLE ho-
loenzyme, as they both share a characteristic histone fold
domain (Figure S1B). Analysis of the skeletal structures of
mutant embryos revealed delayed ossification of the rib and cra-
nial bones; the vertebrae are fused, resulting in shorter tails (Fig-
ure 1B). Of note, mice heterozygous for the mutant allele were
essentially normal (data not shown). Taken together, the com-
plete loss of Pole3 gene function leads to severe defects during
embryonic development, which eventually compromise the
viability of mutant mice. Importantly, however, our results indi-
cate that Pole3 is not absolutely essential for the DNA replication
function of the POLE holoenzyme.
Given the association of skeletal defects and immunodefi-
ciency observed in human patients harboring a hypomorphic
mutation in the gene encoding the catalytic subunit of the
POLE holoenzyme, POLE1 (Pachlopnik Schmid et al., 2012),
we examined Pole3-deficient mice for the presence of defects
in the lymphoid compartment. At E16.5, the thymi of Pole3/
embryos were essentially devoid of double-positive CD4+CD8+
(DP) thymocytes; themajority of cells had the cell surface pheno-
type of DN3 (CD44CD25+) precursors (Figure 1C); heterozy-
gous mice were indistinguishable from wild-type siblings (data
not shown). These results are compatible with a block in transi-
tion from the DN3 to the DN4 (CD44CD25) stage during T cell
differentiation in the thymus or, alternatively, with a general
developmental delay of mutant animals. These results reinforce
Figure 2. Functional Role of the Pole3 C Terminus
(A) Schematic representations of the wild-type Pole3 protein and its variants studied here; the estimated values of the net charge of the C-terminal domains are
indicated.
(B) Alignment of predicted protein sequences of the Pole3 allelic variants. The sequence of the C-terminal domain is highlighted by lowercase characters.
Negatively charged residues are shown in purple and positively charged residues in green fonts.
(C) Total thymocyte numbers per gram of bodyweight inPole3 allelic variants at 4–8 weeks of age. Results frommale and femalemice are pooled, as there was no
difference between sexes; each data point represents one mouse.
(D) Total splenocyte numbers per gram of body weight in Pole3 allelic variants at 4–8 weeks of age.
(E–G) Absolute numbers of CD19+ B cells (E), CD4+ T cells (F), and CD8+ T cells (G) per gram of body weight in the spleen of 4- to 8-week-old Pole3 mice.
(legend continued on next page)






OPEN ACCESSthe notion of a multi-organ pathology in Pole3-deficient embryos
but also demonstrate that tissues differ remarkably in their sensi-
tivity to loss of Pole3. Interestingly, lymphocyte defects in mice
were recently also described after inactivation of the gene en-
coding the fourth component of POLE, namely, Pole4; the
lymphocyte phenotype was part of a complex syndrome domi-
nated by a severe growth defect and interpreted to be the result
of higher sensitivity of specific cell types to compromised stabil-
ity of the POLE holoenzyme (Bellelli et al., 2018b). Because the
phenotype observed in Pole3 null mice described here is very
similar to that described for Pole4 null mice, we propose that
the pathology in these mutant mice is the result of (at least
partially) overlapping molecular perturbations. As mice lacking
functional Pole3 or Pole4 genes survive into late gestation,
they may substitute for each other for certain aspects of their
non-replicative activities.
Functional Role of the Pole3 C Terminus
Although the precise sequences differ, all vertebrate POLE3 pro-
teins possess an acidic C-terminal, which is encoded in exon 4
(Figure S1C). It distinguishes them from vertebrate POLE4 pro-
teins, which lack this type of C-terminal extension (Figure S1B).
This structural difference led us to hypothesize that the C termi-
nus of Pole3 has a distinct function, possibly unrelated to the
DNA replication process. To explore this possibility, we first
created a Pole3 variant (henceforth designated Pole3m1) with
an internal deletion encompassing most of exon 4 (Figure S1D;
Figures 2A and 2B). As a result, the predicted protein of the
mutant allele lacks 45 amino acids (aa), removing residues 97–
140 of this 145 aa protein encoding the two C-terminal a helices
(Figure 2B). Mice homozygous for this allele are viable, are born
at the expected Mendelian ratios (Table S1), and exhibit neither
obvious developmental defects nor postnatal growth delay (Ta-
ble S2). With respect to lymphoid development, we observed a
small but non-significant reduction in the number of thymocytes
(Figure 2C), peripheral lymphocytes in the spleen (Figures 2D–
2G), and B220+ B cells in the bone marrow (Figure 2H); the cell
numbers in Pole3+/m1 heterozygous mutant mice did not differ
from wild-types.
In cultured cells, the C-terminal tail of Pole3 is required for
replication-dependent nucleosome remodeling through the
interaction with the histones H3 and H4 (Bellelli et al., 2018a).
The detrimental effect of the tailless Pole3 version in this setting
contrasts with the mild effect of a similar protein mutant in vivo,
suggesting the presence of efficient compensatory mecha-
nism(s) operating during normal development but unattainable
in the in vitro situation. To circumvent this potential complication
in the phenotypic analysis of Pole3 variants in the organismal
context, we probed the function of the acidic tail of Pole3 more
directly. Specifically, we chose to change the amino acid
composition of the C terminus with the aim of generating neo-
morphic versions of Pole3, in the hope that they would be insen-
sitive to the presumptive in vivo compensation mechanism(s). To(H) Total number of B220+ cells in the bonemarrow of adultPole3mice isolated fro
gram of body weight.
In (C)–(H), the allele tested is shown underneath the bars withmean ±SEM indicate
are indicated); each data point represents one mouse.
4 Cell Reports 31, 107756, June 16, 2020this end, we generated a series of mutations in exon 4 of the
Pole3 gene using the CRISPR-Cas9 technology, three of which
are discussed here. An initial replacement modification (this
allele is henceforth referred to as Pole3m2) retains amino acid
residues 1–95 of the wild-type protein, but then appends 20 aa
residues of unrelated sequence (Figures 2A and 2B). With
respect to the overall charge of the C terminus (the relevant
part of the protein considered for this calculation is indicated in
lowercase letters in Figure 2B), the m2 modification introduces
a net charge of +3 compared with the net charge of 12 for
this domain in the wild-type protein; in this respect, it is similar
to the internal deletionmutant, which has a net charge of2 (Fig-
ure 2A). Mice homozygous for the Pole3m2 allele were born at the
expected frequency (Table S1), with no gross developmental de-
fects, and were viable. However, with respect to lymphoid devel-
opment, a comparison ofPole3m1 andPole3m2 alleles in the state
of homozygosity revealed a more pronounced impairment of
lymphocyte development in the latter, although the magnitude
of the reduction was still only moderate (Figures 2C–2H). Collec-
tively, the results obtained with Pole3m1 and Pole3m2 alleles indi-
cate that the variant C terminus of unrelated sequence as found
in the Pole3m2 alleles may be subject to the same compensation
process as the Pole3m1 allele.
Therefore, in order to generate more effective neomorphic al-
leles, we focused on mutant proteins with greater net positive
charge of the C terminus. We examined two additional mutant
variants that resulted in net charges of +8 (Pole3m3) and +27 (Po-
le3m4), respectively (Figures 2A and 2B). In contrast to the situa-
tion of Pole3m1, Pole3m2, and Pole3m3 alleles, we found that the
homozygous constellation of Pole3m4 was associated with
severely compromised viability. At the age of 3 weeks, only
about 10% of the expected number of Pole3m4/m4 mice were
observed; by contrast, the Pole3+/+ and Pole3+/m4 genotypes
were found in a 1:2 ratio, indicating that the Pole3m4 allele is
not dominant over the wild-type allele (Table S1). The loss of Po-
le3m4/m4 homozygotes occurs during embryogenesis and/or
perinatally, although the precise time point of mutant death
was not determined. The mechanism(s) underlying this impaired
survival are unclear; the distinct genetic backgrounds afforded
by FVB and C57BL/6 mice had no effect on the survival rate.
Of note, surviving Pole3m3/m3 and Pole3m4/m4 homozygous
mutants lacked gross morphological abnormalities, except mi-
nor skeletal deformities in the Pole3m4/m4 mutant mice that
were apparent on the FVB background (Figures S2A and S2B).
With respect to the lymphoid system, mice homozygous for Po-
le3m3 and Pole3m4 alleles exhibited drastic reductions in the
numbers of thymocytes, peripheral lymphocytes, and B220+ B
cells in the bone marrow (Figures 2C–2H); in these respects,
mice heterozygous for the Pole3m3 and Pole3m4 alleles were
found to be indistinguishable from wild-type littermates (data
not shown). Because Pole3m3/m3 homozygotes occupy an inter-
mediate position in the phenotypic spectrum of Pole3C-terminal
mutants, we focused subsequent studies on the Pole3m3 allele.mone lower limb (cells from tibia, femur, and pelvis combined) and given as per
d; wild-type and homozygousmutant animals are compared (p values of t tests
(legend on next page)






OPEN ACCESSThe expression levels of the mutant Pole3 proteins could not be
determined, because all available anti-Pole3 antisera fail to spe-
cifically react with the N terminus (data not shown); however,
transcripts emanating from the mutant alleles are readily detect-
able (Figure S2C).
Stage-Specific Defects of T and B Cell Differentiation in
Pole3 C-Terminal Mutant Mice
Pole3m3/m3 mice exhibited smaller thymi and spleens than their
wild-type littermates (Figure 3A). To avoid the confounding ef-
fects of thymic involution, all mice were age matched and used
at 4–12 weeks of age; the Pole3 mutant phenotypes were still
detectable in aged mice (data not shown). We found that he-
matopoietic precursor subsets (HSCs, MPP1, MPP2, MPP3,
MPP4, and CLP) are not affected in Pole3m3/m3 mutants (Figures
S2D–S2G), indicating that the development of T and B cells is
affected at later stages of lymphoid development. The intrathy-
mic T cell development of Pole3m3/m3 is distinguished by a 50-
fold reduction in the absolute numbers of DP T cells (Figure 3B);
in contrast, the reduction of gd T cells is only about 2-fold (Fig-
ure 3C), pointing to differences in the sensitivity of ab and gd
T cell lineages to the mutant Pole3 proteins. In the mutants,
the proportion of DP thymocytes is decreased, whereas the pro-
portion of double-negative (DN) precursors is increased (Fig-
ure 3D); the accumulation of cells at the DN3 T cell stage sug-
gests a failure to efficiently proceed to the DN4 stage (Figures
3D–3F). The aberrations in intrathymic T cell differentiation are
magnified in Pole3m4/m4 homozygous mice (Figure S3). In both
Pole3m3/m3 and Pole3m4/m4 mice, high levels of apoptosis were
found in DN1, DN2, and DN3 thymocytes (an effect more pro-
nounced in the Pole3m4/m4 mutants) (Figure S4), likely contrib-
uting to the reduced cell numbers in these subsets. However,
from the DN4 stage onward, the differences in viability between
wild-type and mutant cells are less pronounced, suggesting that
the sensitivity to Pole3 mutations changes over developmental
time.
The levels of Cxcr4 expression in Pole3m3/m3 mutant thymo-
cytes are lower than those of their wild-type counterparts (Fig-
ures 3G and 3H). Of note, we observed a rapid loss of Cxcr4
expression from the DN3 to the DN4 stage (Figures 3G and
3H), during which Cxcr4 signals physiologically combine with
signals emanating from the pre-TCR to promote survival and dif-
ferentiation beyond the b-selection checkpoint (Trampont et al.,Figure 3. Stage-Specific Defects of T Cell Differentiation in Pole3 C-Te
(A) Representative images of thymus (top) and spleen (bottom) of adult mice (7 w
(B) Total numbers of CD4+CD8+ (DP) cells in adult thymi.
(C) Total numbers of gd TCR+ T cells in adult thymi.
(D) Flow cytometric analysis of the distribution of thymocyte populations in adult m
of DN progenitor thymocytes (bottom panels), they were gated on CD4CD8Lin
of cells in each gate are shown.
(E) Total numbers (top panel) and frequencies (bottom panel) of thymocyte popu
(F) Cartoon illustrating the developmental stages of T cell differentiation in the thym
(G) Representative histograms of surface expression of CXCR4 in DN3 and DN4
(H) Calculation of mean fluorescence intensity (MFI) of CXCR4 cell surface signa
(I) Representative histograms of surface expression of SCA1 in DN3 and DN4 th
(J) Calculation of mean fluorescence intensity (MFI) of SCA1 cell surface signal o
In (B)–(J), mean ± SEM is indicated; wild-type and homozygousmutant animals ar
of t tests are indicated); each data point represents one mouse.
6 Cell Reports 31, 107756, June 16, 20202010). However, several lines of evidence suggest that the differ-
entiation trajectory of thymocytes as such is not impaired. The
levels of intracellular TCR-b chains in DN3 cells (Figure S5A)
and the density of TCR-b at the cell surface of DP and single-
positive (SP) thymocytes (Figures S5B and S5C) of mutant
mice are indistinguishable fromwild-type littermates. These find-
ings and evidence for rearrangement at the Tcrb locus (Fig-
ure S5D) suggest that failure of VDJ recombination per se does
not underlie the T cell differentiation defect in the mutant mice,
although we cannot exclude subtle alterations in the rearrange-
ment process. Moreover, expression of an ab TCR transgene
(Oxenius et al., 1998) failed to rescue the T cell-deficient pheno-
type of Pole3 mutant mice (Figure S5E).
In the bonemarrow of Pole3m3/m3mice, hematopoietic precur-
sor subsets exhibited increased expression levels of the he-
matopoietic marker stem cell antigen (Sca1; also known as
Ly6A/E) (Figure S5F), which appears to persist into later stages
of lymphoid differentiation (Figures 3I and 3J). This phenotype
is functionally relevant, as loss of Sca1 expression is critical for
the transition through the DN thymocyte stages (Bamezai
et al., 1995; Henderson and Bamezai, 2003). Collectively, low
Crcx4 and high Sca1 levels might synergize to impair the effi-
ciency of T cell development in Pole3m3/m3 mice.
Analysis of B cell development in the bone marrow of Pole3m3/
m3 mice indicated an almost 3-fold reduction of pre-B cell
numbers (B220+IgMCD43) (Figures 4A and 4B); accordingly,
the numbers of IgM+ immature and re-circulating B lymphocytes
were also reduced (Figures 4A and 4B). These data suggest an
incomplete block in the transition from the pro-B
(B220+IgMCD43+CD24+) to the pre-B cell stage (Figure 4C),
functionally analogous to the impaired DN3/DN4 transition in
thymocytes. Mice homozygous for the Pole3m4/m4 allele ex-
hibited similar, albeit more pronounced defects of B cell devel-
opment in the bone marrow (Figures S6A and S6B). We found
that pre-B and immature B cells (but not pre-pro-, pro-, or re-
circulating B cells in the bonemarrow) exhibit significant reduced
viabilities in Pole3m3/m3 (an effect that is even more pronounced
in Pole3m4/m4) mice (Figure S4), reminiscent of the equivalent sit-
uation in thymocytes. However, under the conditions of our con-
ventional mouse house, mature peripheral B cells in Pole3m3/m3
differentiate into switched memory and germinal center B cells
(Figures S6C–S6E); accordingly, germinal centers are readily
detectable in the spleen (Figure S6F), and serumrminal Mutant Mice
eeks of age).
ice stainedwith antibodies against CD4+ andCD8+ (top panels); for the analysis
eage marker (B220CD11bCD11cNK1.1gdTCR) cells. The percentages
lations in adult mice of the indicated genotypes.
us; the dotted linemarks the differentiation block observed inPole3m3/m3mice.
thymocytes.
l on intrathymic T cells.
ymocytes.
n intrathymic T cells.
e compared; in (G)–(J) heterozygous animals are also used as controls (p values
Figure 4. Stage-Specific Defects of B Cell Differentiation in Pole3 C-
Terminal Mutant Mice
(A) Gating strategy for flow cytometric analysis of B cell development in the
bone marrow of Pole3+/+ and Pole3m3/m3 mice. Cells are classified as re-
circulating B cells (B220highIgM+), immature B cells (B220+IgM+), pre-B cells
(B220+IgMCD43+), pre-pro-B cells (B220+IgMCD43+CD24), and pro-B
cells (B220+IgMCD43+CD24+). Numbers indicate percentages of cells in
each gate.
(B) Total numbers of B220+ cells in each B cell stage. The numbers are
representative of whole bone marrow from the lower limbs (cells from femur,
tibia, and pelvis combined) of adult mice. Bars denote mean ± SEM; wild-type
and homozygous mutant animals are compared (p values of t tests are indi-
cated); each data point represents one mouse.
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OPEN ACCESSimmunoglobulin levels in Pole3m3/m3 are comparable with wild-
type levels (Figure S6G).
Collectively, the detrimental lymphocyte-specific outcomes of
Pole3m3 andPole3m4 alleles suggest thatmutant POLE3 proteins
carrying a positively charged C terminus have neomorphic prop-
erties, subverting the compensatory mechanism alleviating the
effects of Pole3m1 and Pole3m2 alleles. Although the efficiency
of B cell development is drastically reduced, mature B cells in
the mutants do not appear to be functionally impaired.
Pole3 Acts in a Cell-Autonomous and Cell Type-Specific
Manner during Lymphocyte Development
To examine the cell autonomy of the T and B cell phenotype in
Pole3m3/m3 mice, competitive whole bone marrow transplanta-
tions of allotype-tagged wild-type and mutant cells were con-
ducted (Figure 5A). To achieve equivalence of biological po-
tency, the mixtures were constructed such that they contained
the same number of hematopoietic stem cells (HSCs) (Lineage
markernegSca1highc-KithighCD150+CD34CD48Flk2) in both
donor sources. The analysis of peripheral blood samples of
recipient mice in 4 week intervals revealed that the overall he-
matopoietic capacity of Pole3m3/m3 bone marrow progenitors
appeared to be inferior to that of their wild-type counterparts
(Figure 5B).
This effect is not the result of an impaired homing capacity of
Pole3m3/m3 HSCs to the bone marrow, as the number of trans-
ferred HSCs found in the bone marrow of recipient mice was
the same for both genotypes, when measured 16 h after trans-
plantation (Figures S7A and S7B). The Pole3m3/m3 mutant bone
marrow preferentially gives rise to myeloid cells compared with
wild-type progenitors (Figure 5C). The failing reconstitution of
both B and T compartments in the recipient mice (Figures 5D
and 5E) essentially recapitulates the phenotype in Pole3m3/m3
mice and provides strong support for the notion that the stromal
microenvironment in the primary lymphoid organs contributes lit-
tle, if anything, to the observed pathology. Impaired hematopoi-
etic reconstitution by Pole3m3/m3 progenitor cells is mirrored in
the composition of lymphocyte populations in primary and sec-
ondary lymphoid organs, respectively. At 16 weeks after trans-
plantation, wild-type CD45.2 and CD45.1 competitor cells
contributed equally well to T cell development in the thymus of
recipient mice, whereas Pole3m3/m3 mutant hematopoietic pro-
genitors failed to repopulate the recipients (Figure 5F). However,
whereas the contributions of Pole3m3/m3 donor cells to DN1,
DN2, and DN3 stages are about 10-fold lower than wild-type
competitors, the contribution of the Pole3m3/m3 cells to later
stages of T cell differentiation falls precipitously and is 2 orders
of magnitude lower than that of wild-type cells from the DP stage
onward (Figures 5F and S7C). Accordingly, only small numbers
of mature Pole3m3/m3-derived CD4+ and CD8+ T cells are found
in the spleen and lymph nodes (Figures 5G, 5H, and S7D). Similar
to the situation in Pole3m3/m3 mice, T cell defects were restricted
to the ab lineage, whereas gd T cell numbers were only mildly
reduced in the periphery (Figures 5G and 5H), again indicative(C) Cartoon illustrating the developmental stages of B cell differentiation in the
bone marrow. The dotted line depicts the differentiation block observed in
Pole3m3/m3 mice. imm., immature B cells; re-circ., re-circulating B cells.
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Figure 5. Pole3 Acts in a Cell-Autonomous and Cell Type-Specific Manner during Lymphocyte Development
(A) Schematic outline of the competitive transplantation assay. Wild-type competitors exhibit the CD45.1 allotype, whereas Pole3+/+ and Pole3m3/m3 test cells are
of CD45.2 allotype. Lethally irradiated CD45.1+/CD45.2+ heterozygous mice served as recipients. The extent of peripheral blood (PB) reconstitution was serially
analyzed at 4, 8, 12, and 16 weeks after transplantation. At 16 weeks, the recipient mice were sacrificed, and lymphoid organs were analyzed for lineage
reconstitution.
(B) Frequency of donor-derived cells (CD45.1+ and CD45.2+) in peripheral blood of recipient mice.
(legend continued on next page)






OPEN ACCESSof a stronger propensity of Pole3m3/m3 progenitors to complete
the gd T cell differentiation pathway.
The pattern of B cell differentiation of Pole3m3/m3 donor cells in
wild-type recipients closely mimicked the phenotype of Pole3m3/
m3 mice, as illustrated by a drastically reduced contribution of
mutant cells to cell types emerging from pre-pro- and pro-B
cell progenitor populations in the bone marrow (Figures 5I and
S7E), resulting in reduced numbers of B cells in peripheral
lymphoid organs (Figures 5G, 5H, and S7D). Collectively, our
studies indicate that the hematopoietic phenotype observed in
Pole3m3/m3 mice is cell intrinsic.
As a result of peripheral lymphopenia, a greater fraction of Po-
le3m3/m3 T cells exhibit the surface phenotype of activated/
effector cells (CD44+CD62L), with a corresponding reduction
of naive cells (CD44–CD62L+) (Figures 6A–6C). In vitro stimula-
tion of carboxyfluorescein succinimidyl ester (CFSE)-labeled
TCR-b+CD8+ splenocytes with a combination of anti-CD3 and
anti-CD28 antibodies showed that mutant cells were largely
similar in their response profile towild-type cells (Figure 6D), indi-
cating that Pole3m3/m3 CD8+ T cells are well capable of prolifer-
ating upon TCR-dependent activation. This observation again in-
dicates that mutant cells can attain a differentiated state and
respond to physiological proliferative stimuli.
The Pole3 Mutation Interferes with Cell Cycle
Progression during T Cell Development
POLE is one of the two major DNA replicases with a peak in activ-
ity during the S-phase of the cell cycle (Langston et al., 2014;
Navas et al., 1995). In order to examine whether and how cell di-
vision is affected in actively dividing cells of the Pole3m3/m3 geno-
type, we first turned to primary cells and analyzed the cell cycle of
adult lung fibroblasts (ALFs). No significant differences in cell cy-
cle progression were observed between wild-type and mutant
ALFs, as indicated by the analysis of EdU incorporation and
DNA content (Figures 7A and 7B). This finding strongly reinforces
the notion that, in contrast to POLE1, POLE3 is not essential for
cell proliferation.
Inhibition of cell cycle proteins selectively affects the differenti-
ation of the ab T cell lineage; to explain this phenomenon, it was
proposed that cell differentiation and proliferation may not always
exhibit an antagonistic relationship (Kreslavsky et al., 2012).
Because the phenotype of mice described here resembles this
particular constellation, we examined the cell cycle dynamics in
developing ab thymocytes of mutant Pole3 mice. For the in vivo
analysis in adult mice, EdU incorporation was determined by
flow cytometry at all stages of intrathymic T cell differentiation.
In contrast to controls, fewer Pole3m3/m3 thymocytes are in early
S-phase, and more cells are found within the fraction with high(C) Contributions of donor cells to the myeloid cell compartment.
(D) Contributions of donor cells to the B cell compartment.
(E) Contributions of donor cells to the T cell compartment.
(F) Contributions of donor cells to the various stages of T cell development in the
(G) Contributions of donor cells to the hematopoietic compartment in the spleen
(H) Contributions of donor cells to the hematopoietic compartment in the lymph
(I) Contributions of donor cells to the various stages of B cell development in the
In (C)–(I), the ratios of CD45.2+ (wild-type or mutant) cells to CD45.1+ competitor c
mutant donors are compared (p values of t tests are indicated); each data pointlevels of EdU incorporation, indicative of late S-phase cells (Fig-
ure 7C). This phenotype suggests that mutant cells progress
through the S-phase faster than their wild-type counterparts;
this phenotype is particularly pronounced within the DN3, DN4,
and DP T cell compartments (Figure 7D). Thymocytes of Pole3
mutants do not suffer increased DNA damage, as shown by the
normal levels of H2AX histone phosphorylation (Figure S7F).
Collectively, mice homozygous for mutant alleles of Pole3 exhibit
changes in cell cycle dynamics for some but not all cell types, and
these changes seem to be unrelated to the ataxia telangiectasia
and Rad3-related (ATR) kinase-pH2AX DNA damage response.
DISCUSSION
The POLE holoenzyme is essential for DNA replication. Yet not all
germline mutations in the gene encoding the catalytic subunit of
the enzyme POLE1 or the second essential component POLE2
are lethal, pointing to the presence of compensatory mecha-
nisms (Zhou et al., 2019) and additional non-replicative functions
of the holoenzyme complex. Indeed, human syndromes associ-
ated with POLE mutations were discovered that present with tis-
sue-specific aberrations, including immunodeficiency (Frugoni
et al., 2016; Logan et al., 2018; Pachlopnik Schmid et al.,
2012), although themechanism(s) by which this tissue specificity
arises from a ubiquitously required complex have remained
obscure. Here, we have addressed this problem by focusing
on possible cell-type-specific roles of one of the two small sub-
units of the complex, POLE3 and POLE4. Several features of
POLE3 suggest that this subunit as a likely candidate for a link
between replicative and non-replicative functions of the POLE
complex. First, POLE3 appears to be a component of chromatin
remodeling complexes (Kukimoto et al., 2004; Poot et al., 2000),
hinting at possible non-replicative functions. Moreover, deletion
of the C terminus of POLE3 does not interfere with the binding of
the hAFC1-SNF2H chromatin remodeling complex (Figure 7E),
suggesting that this binding is mediated by aa residues 1–100
(Kukimoto et al., 2004). In addition, POLE3 and POLE4 form het-
erodimers through interaction of their histone fold domains, in-
dependent of the other two complex components (Li et al.,
2000), andmay thus participate also in other molecular contexts.
Indeed, as the interaction sites of hAFC1-SNF2H and POLE4
overlap, it is likely that the cellular pool of POLE3 is part of func-
tionally distinct protein complexes (POLE3/hAFC1-SNF2H and
POLE3/POLE4, respectively). Finally, POLE3 possesses an
evolutionarily conserved C terminus rich in negatively charged
amino acids that is absent from POLE4 and may serve to





ells are shown. In (B)–(I), mean ± SEM is indicated; wild-type and homozygous
represents one mouse. imm., immature B cells; re-circ., re-circulating B cells.
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Figure 6. Characterization of Peripheral T Cell Subsets
(A) Gating strategy for analysis of CD8+ T cell populations in the spleen of adult mice.
(B and C) Total numbers (B) and frequencies (C) of effector (CD44+CD62L), central memory (CD44+CD62L+), and naive (CD44CD62L+) CD8+ T cell populations
in the spleen of mice with the indicated genotypes.
(D) Analysis of proliferation capacity of CD8+ T cells isolated from the spleen as determined by CFSE dilution following stimulation with antibodies against CD3
and CD28. Proliferation (left panel) and division indices (right panel) are shown. Bar graphs indicate mean ± SEM; p values of pairwise comparisons by t test are
shown; each data point represents one mouse.
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OPEN ACCESSIn tissue culture cells, theC terminus of POLE3was shown to be
required for replication-dependent nucleosome remodeling
through the interaction with the histones H3 and H4 (Bellelli et al.,
2018a). However, unexpectedly, we observed no deleterious
phenotype in mice homozygous for the Pole3DCmutant, pointing
to the presence of a compensation mechanism, which can buffer
such ill effects in the organismal context but not in tissue culture.
A different experimental strategy was therefore required to over-
come such compensatory mechanism(s) and to be able to
examine the role of the C terminus in POLE3-containing com-
plexes other than POLE3/H3-H4. When the predominantly nega-
tively charged tail was converted to positively charged versions,
a non-redundant function of this domain for lymphocyte develop-
ment was revealed. Because deletion of the entire C terminus has
no effect on lymphocyte development, we conclude that the neo-
morphic alleles counteract the function of POLE3 in a distinct pro-
tein complex, wherein a lymphocyte stage-specific factor(s) binds
to theN-terminalhalfof theprotein (aa1–96).Becauseof the lackof
a specificPole3antibody that recognizes theN-terminal domainof
the protein, it was not possible to directly demonstrate the pres-
ence of the mutant proteins. However, the distinct phenotypes
observed inourmouse lines stronglyargue that theneomorphical-
leles give rise to appreciable amounts of mutant proteins.
The rapid progression through the S-phase in our Pole3
mutant thymocytes is in line with the observation that the
Pole3 yeast homolog (Dpb4) controls the activation of the S-
phase checkpoint under conditions of replication stress (Puddu
et al., 2011). Moreover, the fact that changes in Pole3 function
are associated with increased sensitivity to ATR kinase inhibition
(Hustedt et al., 2019) suggests that in addition to the ATR
pathway, a Pole3-dependent mode of cell cycle regulation ex-10 Cell Reports 31, 107756, June 16, 2020ists. Our results suggest that the latter is particularly important
in the lymphoid lineage.
Our study shows that the arrest of lymphocyte differentiation
occurs at equivalent stages during T and B cell development in
Pole3mutant mice. This suggests that the non-replicative activity
of POLE3 targets a component(s) shared by the two principal lym-
phocytes lineages, which becomes functionally critical at the DN3
stage of T cell differentiation and at the pre-B cell stage in B cell
development. From an evolutionary perspective, this suggests
that POLE3 became incorporated into the genetic network direct-
ing the differentiation of lymphocyte-like cells already in the com-
mon ancestor of vertebrates, and possibly even earlier. This func-
tional requirement was maintained at early stages of vertebrate
evolution during the time when the two principal lymphocyte line-
ages emerged and assumed their different functions in the adap-
tive immune system. The emergence of a novel interaction partner
for POLE3 may have been accompanied by subtle modifications
in the protein sequence of POLE3 itself, so that it could maintain
its replicative function while expanding the range of participation
in cell-type-specific protein complexes.
In summary, we have identified the POLE3 subunit of the POLE
holoenzyme as a multi-functional protein that connects the repli-
cative function of the POLE holoenzyme and a non-replicative
activity in lymphocytes. We anticipate that more immunodefi-
ciency syndromes will be discovered that can be linked to
such non-canonical functions of large protein complexes.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
Figure 7. The Pole3 Mutation Interferes with Cell Cycle Progression during T Cell Development
(A) Representative cell cycle profiles of adult lung fibroblasts (ALFs) isolated fromPole3+/+ andPole3m3/m3mice. EdU intensity increaseswith progression through
the S-phase of the cell cycle (left panels). The cell cycle stages are characterized by their EdU incorporation and DNA content profiles (right panels): G0/G1 phase
(EdU-negative, 2n DNA content), S phase (EdU-positive, 2n to 4n DNA content), and G2/M phase (EdU-negative, 4n DNA content).
(B) Quantification of cell cycle profiles of ALFs is shown. Bar graphs indicate mean ± SEM.
(C) Representative histograms of EdU incorporation of indicated thymocyte populations in adult mice of the indicated genotypes.
(D) Quantification of cell cycle stages for the indicated stages of thymocytes. Bar graphs indicate mean ± SEM. Significance levels as determined by t test are
indicated: *p < 0.05 and **p < 0.002.
(E) Schematic representation of interaction surfaces of POLE3 proteins. The N-terminal region of the protein (1–100 aa) was shown to interact with the human
nucleosome sliding complex hACF1-SNF2H and with POLE4. The C-terminal domain (96–145 aa) was shown to interact with a complex composed of histones
H3-H4 in tissue culture cells but is dispensable for lymphocyte development in vivo. Lymphocyte-specific protein interactions of Pole3 are abolished when the
negative charge of the C terminus is converted to a positive charge.
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Antibodies
CD4 APC Cy7 Clone GK1.5 Biolegend Cat#100414
CD8a PE Clone 53-6.7 eBioscience Cat#12-0081-85
CD44 APC Clone IM7 eBioscience Cat#17-0441-81
CD25 PE Cy7 Clone PC61 BD Biosciences Cat#552880
B220 (CD45R) FITC Clone RA3-6B2 Biolegend Cat#103206
TCR gd FITC Clone eBioGL3 eBioscience Cat#11-5711-82
NK1.1 FITC Clone PK136 Biolegend Cat#108706
CD11c FITC Clone HL3 BD Biosciences Cat#557400
CD11b (Mac1) FITC Clone M1/70 BD Biosciences Cat#557396
CD4 PE Dazzle Clone GK1.5 Biolegend Cat#100455
CD8a BV421 Clone 53-6.7 Biolegend Cat#100738
TCR gd PerCP Cy5.5 Clone GL3 Biolegend Cat#118118
B220 (CD45R) PE Clone RA3-6B2 Biolegend Cat#103208
NK1.1 PE Clone PK136 eBioscience Cat#12-5941-83
CD11c PE Clone N418 eBioscience Cat#12-0114-82
CD11b (Mac1) PE Clone M1/70 BD Biosciences Cat#553311
TCR-b PE Clone H57-597 eBioscience Cat#12-5961-83
CXCR4 (CD184) PE Clone L276F12 Biolegend Cat#146506
CD44 PE Clone IM7 BD Biosciences Cat#553134
CD25 Alexa Fluor 647 Clone PC61 Biolegend Cat#102020
Sca1 (Ly-6A/E) PE Cy7 Clone D7 Biolegend Cat#108113
IgM FITC Clone II/41 BD Biosciences Cat#553437
BP-1 (Ly51) PE Clone 6C3 Thermo Fischer Cat#12-5891-83
CD43 APC Clone S7 BD Biosciences Cat#560663
B220 (CD45R) PE Cy7 Clone RA3-6B2 eBioscience Cat#25-0452-82
CD24 eFluor 450 Clone M1/69 eBioscience Cat#48-0242-82
IgM PE Clone II/41 eBioscience Cat#12-5790-81
CD3 PerCP Cy5.5 Clone 145-2C11 Biolegend Cat#100328
CD3 PE Clone 145-2C11 Biolegend Cat#100308
Fas (CD95) APC Clone SA367H8 Biolegend Cat#152603
GL7 BV421 Clone GL7 BD Biosciences Cat#562967
IgM eFluor 450 Clone II/41 eBioscience Cat#48-5790-82
IgD Alexa Fluor 647 Clone 11-26c.2a Biolegend Cat#405707
GL7 Alexa Fluor 488 Clone GL7 Biolegend Cat#144612
B220 (CD45R) Alexa Fluor 647 Clone
RA3-6B2
BD Biosciences Cat#557683
CD169 (Siglec-1) BV421 Clone 3D6.112 Biolegend Cat#142421
CD25 BV605 Clone PC61 Biolegend Cat#102035
CD8a PE Clone 53-6.7 Cy7 eBioscience Cat#25-0081-82
CD4 PE Dazzle Clone GK1.5 Biolegend Cat#100455
TCRb BV421 Clone H57-597 Biolegend Cat#109229
CD62L Alexa Fluor 700 Clone MEL-14 Biolegend 104426
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CD44 APC Clone IM7 eBioscience Cat#17-0441-81
CD19 PE Clone eBio1D3 eBioscience Cat#12-0193-83
CD3e FITC Clone 145-2C11 Biolegend Cat#100306
Gr1 (Ly-6G/Ly-6C) FITC Clone RB6-8C5 Biolegend Cat#108406
TER-119 FITC Clone TER-119 eBioscience Cat#11-5921-81
Sca1 (Ly-6A/E) APC Clone D7 eBioscience Cat#17-5981-81
Ckit (CD117) BV421 Clone 2B8 Biolegend Cat#105827
Flk2 (CD135) PE Clone A2F10.1 BD Biosciences Cat#561068
CD34 Alexa Fluor 700 Clone RAM34 eBioscience Cat#56-0341-82
CD150 (SLAM) BV605 Clone TC15-12F12.2 Biolegend Cat#115927
CD48 APC Cy7 Clone HM48-1 Biolegend Cat#103431
IL-7Ra PE Dazzle Clone A7R34 Biolegend Cat#135031
Flk2 (CD135) PerCP efluor710 Clone A2F10 eBioscience Cat#46-1351-80
CD45.1 PE Clone A20 eBioscience Cat#12-0453-83
CD45.2 BV421 Clone 104 Biolegend Cat#109831
CD3e APC Clone 145-2C11 Thermo Fischer Cat#17-0031-82
CD48 PerCP efluor710 Clone HM48-1 eBioscience Cat#46-0481-82
CD150 (SLAM) PE Dazzle Clone TC15-
12F12.2
Biolegend Cat#115935
CD45.2 Alexa Fluor 700 Clone 104 Biolegend Cat#109822
CD45.1 APC Cy7 Clone A20 Biolegend Cat#110716
CD4 PE Cy7 Clone GK1.5 Biolegend Cat#100422
CD43 PE Clone S7 BD Biosciences Cat#553271
Gr1 (Ly-6G/Ly-6C) PE Clone RB6-8C5 Biolegend Cat#108408
gH2AX (phospho-Ser139) mouse
monoclonal antibody (clone JBW301)
Millipore Cat#05-636, RRID:AB_309864
Pan-actin rabbit polyclonal antibody Sigma Cat#A2066, RRID:AB_476693
Goat anti-rabbit Immunoglobulins/ HRP Agilent Dako Cat#P0448,
Goat anti-mouse Immunoglobulins/ HRP Agilent Dako Cat#P0447






Recombinant Cas9 Protein PNA Bio Inc Cat#CP01
a-GalCer Loaded CD1 tetramer PE ProImmune Cat#E001-2X
Critical Commercial Assays
Click-iT EdU Flow Cytometry Assay, Alexa
Fluor 488 dye
Thermo Fisher Cat#C10337
FoxP3/Transcription staining buffer set eBioscience Cat#00-5523-00
Superscript II Reverse Transcription Thermo Fischer Cat#18064022
IgM Mouse Uncoated ELISA Kit Thermo Fischer Cat#88-50470
IgG (Total) Mouse Uncoated ELISA Kit Thermo Fischer Cat#88-50400
IgG1 Mouse Uncoated ELISA Kit Thermo Fischer Cat#88-50410
IgG2b Mouse Uncoated ELISA Kit Thermo Fischer Cat#88-50430
IgG2c Mouse Uncoated ELISA Kit Thermo Fischer Cat#88-50670-22
Annexin V Apoptosis Detection Kit FITC Thermo Fisher Cat#88-8005-72
Experimental Models: Cell Lines
Pole3tm1(KOMP)Vlcg ESC line, Clone 12086A-
F4
KOMP Repository UC Davis Strain ID: C57BL/6- Pole3 tm1(KOMP)Vlcg,
Design ID: 12086
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this paper, Pole3tm1(KOMP)Vlcg ESC line from
KOMP Repository UC Davis
N/A
Oligonucleotides
guide RNA sequences (sgRNA) and DNA
repair template for CRISPR-Cas9
mutagenesis
this paper, see Table S3 for sequences N/A
Genotyping primers for Pole3 mutants and
TCRtg
this paper, see Table S4 for sequences N/A
RT-PCR Primers this paper, see Table S5 for sequences N/A
Recombinant DNA
DR274 (guide RNA expression vector) (Hwang et al., 2013) Addgene plasmid Cat#42250
Software and Algorithms
FlowJo version 10 FlowJo https://www.flowjo.com/solutions/flowjo/
downloads
Photoshop CC Adobe https://www.adobe.com
Illustrator Adobe https://www.adobe.com












Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Thomas
Boehm (boehm@ie-freiburg.mpg.de).
Materials Availability
All unique reagents generated in this study are available from the lead Contact with a completed Materials Transfer Agreement.
Mouse lines generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.
Data and Code Availability
The published article includes all datasets generated or analyzed during this study.e3 Cell Reports 31, 107756, June 16, 2020
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Mice
ES cells carrying a deletion cassette replacing most of the Pole3 coding sequence were obtained from the KOMP repository and
were injected into host blastocysts to generate Pole3/ mice under the C57BL/6 genetic background using standard protocols.
Pole3 C-terminal domain mutants (Pole3m1, Pole3m2, Pole3m3, Pole3m4 mutants) were generated by CRISPR-Cas9 technology
using recombinant Cas9, sgRNAs and, in one experiment, a sequence-specific single-stranded repair oligonucleotide (listed in
Table S3) targeting the last exon of the murine Pole3 gene, according to standard methods. The deletion in exon 4 was gener-
ated by co-injection of two sgRNAs; owing to the presence of a long string of glutamic acid residues in the wild-type protein
(Figure 2B) and the similarity of triplets encoding glutamic acid on the one hand (GAA and GAG), and lysine (AAA and AAG) on
the other, the imperfect repair processes after Cas9-mediated double-strand breaks generated a variety of mutant alleles by
small insertions/deletions, some of which were selected for further study (see Table S3). Pole3 C-terminal domain mutants
were generated on the FVB genetic background and were either kept on that background or were backcrossed to the
C57BL/6 strain. Mice expressing a MHC Class II restricted TCR recognizing Lymphocytic Choriomeningitis Virus (LCMV)
derived epitope were previously described (Oxenius et al., 1998).
The primers used for mouse genotyping are listed in Table S4. For all experimental procedures, comparisons were made
with same-strain littermates in order to exclude strain-specific variations. All mice were kept in the animal facility of the Max
Planck Institute of Immunobiology and Epigenetics under conventional housing conditions. All animal experiments were per-
formed in accordance with the relevant guidelines and regulations, approved by the review committee of the Max Planck
Institute of Immunobiology and Epigenetics and the Regierungspra¨sidium Freiburg, Germany (license AZ 35-9185.81/G-
15/35).
METHOD DETAILS
CRISPR-Cas9 mediated gene editing in the mouse
For gene editing a single guide RNA (sgRNA) approximately 21 nucleotides long was designed complementary to a target site in the
genome and was cloned in a pDR274 vector containing a T7 promoter for in vitro transcription (sgRNAs listed on Table S3). 15 ng/ml
transcribed sgRNA together with 50 ng/ml recombinant Cas9 protein and 5 mM of sequence specific single stranded repair oligo (in
case of knock-in gene editing) were mixed together in injection buffer (20 mM Tris Hcl pH 7.5, 0.3 mMEDTA in nuclease free ddH2O).
Themixturewas injected intomouse blastocysts and thosewere transferred into pseudo-pregnant recipientmice; the procedurewas
carried out in the Transgenic Mouse Core Facility of the MPI-IE. Upon obtaining founder mice (F0), the desired mutations were iden-
tified by genotyping.
Alcian Blue/Alizarin Red staining
Skeletal structures of embryos were revealed by Alcian Blue-Alizarin Red staining (Rigueur and Lyons, 2014). In brief, embryos were
collected at 16.5 days post coitum (dpc) and extra-embryonic membranes were removed. After washing in PBS, the embryos were
briefly immersed in hot tap water (65C) and the eyes, skin and internal organs were removed. They were fixed overnight in 95%
ethanol at room temperature and then placed in acetone overnight at room temperature to dissolve excess fat. For cartilage staining,
the embryos were incubated for 24h in Alcian Blue stain (0.03% Alcian Blue [w/v], 80% EtOH, 20% glacial acetic acid) at room tem-
perature and then destained in two changes of 70% ethanol (4 hours in total), followed by incubation in 95% ethanol overnight. After
pre-clearing the embryos with 1% KOH for 1 h, they were immersed in Alizarin Red solution (0.005% Alizarin Red [w/v] in 1% [w/v]
KOH) for 4h at room temperature. The embryos were cleared for 24h-36h at 4C in 50% glycerol, 0.5% (w/v) KOH solution and then
transferred to 80%glycerol (in ddH2O) for long-term storage. Pictures were taken using a LeicaMZ FLII stereomicroscope on a trans-
mitted light base.
Flow cytometry and cell sorting
Phenotyping of lymphocyte populations was performed by flow cytometry after preparation of single cell suspensions from
lymphoid organs and staining using antibodies listed in Table S6. Single cell suspension of thymus, spleen and lymph nodes
were prepared in FACS buffer (2% FBS, 1 mM EDTA, 1% penicillin- streptomycin, in PBS) by tissue homogenization with a
syringe plunger against a 40 mm cell strainer. For preparation of cell suspensions from bone marrow, femur, tibia and pelvis
were flushed with FACS buffer using a 10 mL syringe and a 26 gauge-needle and then passed through 40 mm cell strainer
to obtain single cell suspensions. To achieve red blood cell lysis, the cell suspensions were treated with ACK lysis buffer
(0.15M NH4Cl, 10mM KHCO3, 0.1mM EDTA in H2O, pH 7.2-7.4), washed and resuspended in FACS buffer. For intracellular
staining the cells were first stained with a fixable viability dye prior to surface antibody staining. After cell surface staining
the cells were fixed and permeabilized using the FoxP3/Transcription staining buffer set (eBioscience) according to manu-
facturer’s protocol followed by intracellular antibody staining. Data were collected on an LSRFortesa and/or LSRII apparatus
(BD Biosciences) and were analyzed with FlowJo software version 10; cell sorting was done using a FACSAria instrument
(BD Biosciences).Cell Reports 31, 107756, June 16, 2020 e4
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The Annexin V (FITC) apoptosis detection Kit (eBioscience) was used for detection of apoptotic cells during development of T and B
lymphocytes. Cell suspensions prepared from thymus and bone marrow were first labeled with a viability dye (Fixable viability dye
eFluor 780, eBioscience) according tomanufacturer’s instructions. Then the cells were stainedwith surface antibodies (listed in Table
S6) in FACS buffer (2%FBS, 1mMEDTA, 1%penicillin- streptomycin, in PBS). After washing with 1X-diluted Binding Buffer (in dH2O)
they were resuspended again in 1X Binding Buffer and incubated with FITC-conjugated Annexin V for 15 minutes at room temper-
ature. The cells were finally washed with 1X Binding Buffer and analyzed by flow cytometry.
Semiquantitative RT-PCR
Total RNA was extracted frommouse tissue-derived cells using TriReagent (Sigma Aldrich) following the manufacturer’s recommended
protocol. To remove genomicDNA, RNApreparationswere treatedwith 1UofRQ1RNase-freeDNase (Promega) permgof total RNA in a
reactioncontaining1XRQ1RNase-freeDNaseReactionbuffer. Themixturewas incubatedat37Cfor30minutes.Asecond roundofRNA
extraction using TriReagentwas performed to remove theDNase from the sample. The quantity and quality of theRNAwere assessedby
Nanodrop concentration measurement and agarose gel electrophoresis (1.5% agarose gel). For cDNA synthesis the Superscript II
Reverse Transcriptase (Thermo Fischer) and oligo(dT1-3) primers were used according to manufacturer’s recommended protocol. The
obtained cDNA was serially diluted for PCR reactions with Pole3 and phosphoribosyl transferase (Hprt) housekeeping gene primers.
Immunoblotting
For use inwestern blotting, wholemouse tissuewas homogenized and lysed for 15-30min at 4C in RIPA lysis buffer (Millipore, Cat#20-
188) [50 mM tris-HCl (pH 7.4), 150 mM NaCl, 1x EDTA, 1% NP40, 0,25% sodium deoxycholate] supplemented with 0,1% Sodium do-
decyl sulfate, protease inhibitor cocktail (Roche, Cat#11836170001) and 1% of each phosphatase inhibitor cocktail 2 and 3 (Sigma,
Cat#P5726 and Cat#P0044). Lysates were centrifuged at 18,000xg for 10min and the supernatant was transferred to a fresh tube prior
to snap freezing. Protein lysates were denatured at 95C in 1X loading buffer (2% SDSw/w, 2mMDTT, 4%Glycine, 0.01% bromophe-
nol bluew/w, 0.04MTris pH6.8, 3%b-mercaptoethanol). SDS–polyacrylamidegel electrophoresis (SDS-PAGE) of heat-denaturedpro-
tein samples was performed using the NuPAGE SDS-PAGE Gel System and 12% NuPAGE Bis-Tris Precast Gels with MES/SDS
running buffer (Thermo Fischer). Blotting to Immuno-Blot PVDF membrane (Biorad) in transfer buffer (25mM Tris, 192mM Glycine,
20% MeOH v/v) was performed for 40 min at 100V using a Mini Trans-Blot Cell Module (Biorad). Membranes were blocked using
5%Bovine Serum Albumin and developed with the following antibodies at dilutions recommended by the manufacturer: anti-phospho
Histone H2AX (Ser139), and anti-pan-actin. Membranes were probed with goat a-rabbit-HRP secondary or goat a-mouse-HRP sec-
ondary antibodies. A chemiluminescent system was used for imaging western blots using ECL Prime Western Blotting Detection Re-
agents (GE Healthcare) or SuperSignal WestFemto (Thermo Fischer); CX-BL+ X-ray film (AGFA Healthcare) was used for documenta-
tion. Contrast and brightness were adjusted for total images using Adobe Photoshop CS6.
ELISA Immunoassay for serum Immunoglobulins
Serum immunoglobulin levels of mice were measured by enzyme-linked immunosorbent assay (ELISA) according to manufacturer’s
instructions (Invitrogen). Serum was prepared from mouse whole blood and was pre-diluted to be used for ELISA assays. The levels
of each immunoglobulin class were expressed as arbitrary unit (AU) per mL serum. These values were interpolated from a standard
curve. This curve was generated from a serial dilution of purified mouse immunoglobulin isotype control. One AU corresponds to the
OD values obtained with 1 mg purified isotype control upon serial dilution.
Immunofluorescence staining of frozen spleen sections
For spleen immunofluorescence staining, frozen spleen sections (8 mm) were prepared with a cryostat on Superfrost Plus 253 753
1 mm microscopy slides (Thermo Fischer). After drying for 20 minutes at room temperature, the sections were surrounded with pap
pen and left to dry. The slides were washed for 1 min in PBS and blocked in 1%BSA, 0,2% Tween in PBS for 1 h. The spleen sections
were stained with the following fluorescently labeled antibodies at 4C in a humid chamber in the dark overnight: GL7 Alexa Fluor
488, CD169 BV421 and B220 Alexa Fluor 647. The slides were washed three times with PBS and briefly with ddH20. Dried slides
were mounted with Fluoromount G (Thermo Fischer). Imaging was done using a LSM780 (Zeiss) microscope and images were pro-
cessed using Imaris 9.5.1 software (Bitplane). Tiled Immunofluorescent images were stitched together using Zen software (Zeiss).
Contrast, brightness and color saturation were adjusted across the entire images using Adobe Photoshop CS6.
Adult Lung Fibroblast (ALF) isolation and short-term in vitro culture
For ALF isolation, lungs from euthanized mice were harvested and finely minced with scissors. The lung fragments were digested in
1 mL of digest media (0.2 mg/mL collagenase, 0.2 mg/mL dispase and 2.5 mg/mL DNaseI in RPMI 1640, supplemented with 2% FBS
and 1 U/mL penicillin- 1 mg/mL streptomycin) for 1h at 37C. Digestion was stopped by adding 5 mM EDTA, the cells were filtered
through a 70 mM cell strainer and washed with RPMI 1640 supplemented with 2% FBS (Pan-Biotech) and 1 U/mL penicillin- 1 mg/mL
streptomycin. Cell suspension was pelleted and resuspended in DMEM (Dulbecco´s modified Eagle´s medium) supplemented with
10% FBS and 1 U/mL penicillin- 1 mg/mL streptomycin. The cells were plated in T75 flasks (passage 0) and incubated at 37C
with 5% CO2. At 70% confluence, the cells were trypsinized, counted and replated on 12-well plates for EdU labeling.e5 Cell Reports 31, 107756, June 16, 2020
Article
ll
OPEN ACCESSEdU staining and cell cycle analysis
For in vivo cell cycle analysis of thymocytes, mice received a single intra-peritoneal injection of EdU (5-ethynyl-2’-deoxyuridine)
diluted in PBS at a dose of 50 mg/kg body weight. After 16h of EdU exposure, the mice were sacrificed and single cell suspensions
of thymus were prepared. Single cell suspensions of EdU labeled cells were processed using the Click-iT EdU FlowCytometry Assay
(Thermo Fisher) according to themanufacturers protocol. Briefly, the cells werewashedwith 1%BSA in PBS and stainedwith surface
antibodies (listed in Table S6) at 4C. The cells were washed again and fixed in Click-iT fixative for 15 min, washed once and then
permeabilized in saponin-based permeabilization and wash reagent for 15 min. The Click-iT reaction cocktail was added to the cells
for additional 30 min incubation. The cells were finally washed and analyzed by flow cytometry. All steps after the cell surface anti-
body staining were carried out at room temperature.
For in vitro cell cycle analysis of adult lung fibroblasts (ALFs), isolated ALFs (passage 1) were labeled with 20 mM EdU. After 2h
incubation, single cells were harvested by trypsinization and were processed as previously described according to the Click-iT
EdU Flow Cytometry Assay. After the Click-iT reaction, the cells were counterstained for DNA content by Hoechst 33258 (1 mg/
mL) (Thermo Fischer) and analyzed by flow cytometry.
CFSE cell proliferation assay of sorted CD8+ T cell populations
To analyze the proliferative response of CD8+ T cells upon TCR-dependent stimulation, splenic cell suspensions were prepared in
37C pre-warmed PBS at a concentration of 50 3 106 cells/mL and labeled with CFSE (Cayman Chemicals) at a concentration of
2.5 mM for 10 min at 37C in the dark. CFSE labeling was stopped by addition of 9 volumes of ice-cold T cell media (10% FBS,
1 mM non-essential amino acids, 1mM sodium pyruvate, 10 mM HEPES, 10 U/mL penicillin-10 mg/mL streptomycin, 0.1 mM b-mer-
captoethanol in RPMI 1640 with L-glutamine). The cells were washed and stained with surface antibodies (listed in Table S6) for cell
sorting of CD8+ T cell splenic populations according to the gating strategy shown in Figure 6A. Sorted cells were washed in T cell
media and were seeded in straight bottom 96-well plates that were coated overnight at 4C with 1 mg/ml anti-CD3 and anti-CD28
antibodies. After 42h of incubation at 37C with 5% CO2, dead cells were labeled with Propidium Iodide (0.08 mg/mL) (Thermo
Fischer) and CFSE dye dilution was analyzed by flow cytometry. The division index and proliferation index were calculated using
the FlowJo version 10 proliferation tool. The division index depicts the average number of cell divisions completed by a cell of the
original population (including undivided cells), while the proliferation index represents the number of cell divisions divided by the num-
ber of cells that completed at least one cell division.
Competitive bone marrow reconstitution
Bone marrow (BM) cell suspensions from CD45.2 Pole3+/+, CD45.2 Pole3m3/m3, and CD45.1 wild-type mice (7-12 weeks of age) were
prepared and an aliquot was stained with surface antibodies (listed in Table S6) for flow cytometric determination of HSCs. Two bone
marrow cell suspensions of the desired donors, each containing 50 HSCs, were combined from the required sources before transplan-
tation.ThemixturesofCD45.1andCD45.2bonemarrowcellswere resuspended in100mLPBSand transplanted into lethally irradiated (a
total of 9.5Gydelivered in twodosesof 5Gyand4.5Gy, separatedbya3h interval) CD45.1/2heterozygote recipientmice (7-12weeksof
age) by tail vein injection. Peripheral bloodwas obtained from the recipientmice at 4, 8, 12 and 16weeks after transplantation. Following
redbloodcell lysis, thecontributionsofCD45.2+donorderivedcells to theTcell (CD3+),Bcell (B220+) andmyeloid (CD11b/Gr1+) lineages
were assessed by flow cytometry (see antibodies in Table S6). At 16 weeks after transplantation, the mice were sacrificed and BM,
thymus, spleen and lymph nodes were collected for flow cytometric analysis using the antibodies listed in Table S6.
Analysis of TCRb rearrangements
To determine the presence of TCRb rearrangements, thymocyte suspensions were sorted into CD8+ SP, CD4+ SP and DP popula-
tions (using surface antibodies listed in Table S6), resuspended in 1x lysis buffer (10 mM Tris-HCl [pH 8.3], 50mM KCl, 0.01 mg/ml
gelatin, 0.045%Nonidet P-40, 0.045%Tween20) including 0.1 mg/ml Proteinase K andwere incubated at 55C for 1h to overnight and
finally at 95C for 10 min to inactivate the protease. TCRb rearrangements were determined following a previously described method
(Kawamoto et al., 2000). In brief, cell lysates were directly used as templates for PCR amplification using the following primers: Db2,
50-GCACCTGTGGGGAAGAAACT-30; Jb2.6, 50-TGAGAGCTGTCTCCTACTATCGATT30. The PCR products were loaded on a 1.2%
agarose gel and after electrophoresis were stained with GelRed for documentation.
Image processing
Uneven light on image background and shadows were removed in Photoshop CC for photos of mouse embryos. For mouse skeletal
images (Alcian Blue- Alizarin Red staining), focused z stack imaging consisting of multiple segmented tiles was performed in Photo-
shop CC to capture the embryo in its entirety.
QUANTIFICATION AND STATISTICAL ANALYSIS
Graphs were generated and analyzed using the GraphPad Prism software. The data are shown as mean ± s.e.m. Statistical signif-
icance was determined by unpaired two tailed t tests. P values of pairwise comparisons and number of animals (n) are depicted in
each graph. Statistical details of experiments can be found in the figure legends.Cell Reports 31, 107756, June 16, 2020 e6
